Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment
Davida F Kruger,1 Susan LaRue,2,3 Phil Estepa31Henry Ford Health System, Detroit, MI, USA; 2Amylin Pharmaceuticals, San Diego, CA, USA; 3AstraZeneca, San Diego, CA, USAAbstract: Injectable treatments, such as glucagon-like peptide-1 receptor agonists and insulin, are options for the pharmacologic t...
Main Authors: | Kruger DF, LaRue S, Estepa P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-01-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Online Access: | http://www.dovepress.com/recognition-of-and-steps-to-mitigate-anxiety-and-fear-of-pain-in-injec-peer-reviewed-article-DMSO |
Similar Items
-
Appraisal of Nonpharmacological Chronic Pain Management
by: Anthony, Yvonne LaRue
Published: (2017) -
Differential effects of experimentally induced anxiety and fear on pain: the role of anxiety sensitivity
by: Metzger S, et al.
Published: (2019-06-01) -
Anxiety Sensitivity, Fear of Pain and Pain-Related Disability in Children and Adolescents with Chronic Pain
by: Andrea L Martin, et al.
Published: (2007-01-01) -
An Evaluation of Glucagon Injection Anxiety and Its Association with the Fear of Hypoglycemia among the Parents of Children with Type 1 Diabetes
by: Serra Muradoğlu, et al.
Published: (2021-09-01) -
Differential effects of experimentally induced anxiety and fear on pain: the role of anxiety sensitivity [Corrigendum]
by: Metzger S, et al.
Published: (2019-07-01)